Unclassifiable interstitial lung disease and autoimmunity: Towards IPAF in children?
autoimmunity
children
connective tissue disease
intersitial lung disease
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
14
07
2023
received:
04
01
2023
accepted:
19
08
2023
medline:
23
10
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis. Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD-ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD-ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD-ILD group, p = .07). We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD-ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3303-3313Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Liang T, Vargas SO, Lee EY. Childhood interstitial (Diffuse) lung disease: pattern recognition approach to diagnosis in infants. Am J Roentgenol. 2019;212:1-10.
Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120-1128.
Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188(3):376-394.
Fan LL, Dishop MK, Galambos C, et al. Diffuse lung disease in biopsied children 2 to 18 years of age. application of the chILD classification scheme. Ann Am Thorac Soc. 2015;12(10):1498-1505.
Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976-987.
Jee AS, Parker MJS, Bleasel JF, et al. Baseline characteristics and survival of an Australian interstitial pneumonia with autoimmune features cohort. Respiration. 2021;100(9):853-864.
Oldham JM, Adegunsoye A, Valenzi E, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016;47(6):1767-1775.
Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A. Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med. 2016;119:150-154.
Ahmad K, Barba T, Gamondes D, et al. Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. 2017;123:56-62.
Ito Y, Arita M, Kumagai S, et al. Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features. BMC Pulm Med. 2017;17(1):111.
Dai J, Wang L, Yan X, et al. Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study. Clin Rheumatol. 2018;37(8):2125-2132.
Yoshimura K, Kono M, Enomoto Y, et al. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia. Respir Med. 2018;137:167-175.
Kelly BT, Moua T. Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology. 2018;23(6):600-605.
Lim JU, Gil BM, Kang HS, Oh J, Kim YH, Kwon SS. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis. BMC Pulm Med. 2019;19(1):120.
Sambataro G, Sambataro D, Torrisi SE, et al. Clinical, serological and radiological features of a prospective cohort of interstitial pneumonia with autoimmune features (IPAF) patients. Respir Med. 2019;150:154-160.
Tian M, Huang W, Ren F, et al. Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features. Clin Rheumatol. 2020;39(2):575-583.
Jiwrajka N, Loizidis G, Patterson KC, et al. Identification and prognosis of patients with interstitial pneumonia with autoimmune features. J Clin Rheumatol. 2022;28(5):257-264.
Collins BF, Spiekerman CF, Shaw MA, et al. Idiopathic interstitial pneumonia associated with autoantibodies. Chest. 2017;152(1):103-112.
Kim HC, Lee JH, Chae EJ, Song JS, Song JW. Long-term clinical course and outcome of interstitial pneumonia with autoimmune features. Respirology. 2020;25(6):636-643.
Sebastiani M, Cassone G, De Pasquale L, et al. Interstitial pneumonia with autoimmune features: a single center prospective follow-up study. Autoimmun Rev. 2020;19(2):102451.
Decker P, Sobanski V, Moulinet T, et al. Interstitial pneumonia with autoimmune features: evaluation of connective tissue disease incidence during follow-up. Eur J Intern Med. 2022;97:62-68.
Mackintosh JA, Wells AU, Cottin V, Nicholson AG, Renzoni EA. Interstitial pneumonia with autoimmune features: challenges and controversies. Eur Respir Rev. 2021;30(162):210177.
Tang X, Li H, Liu H, et al. Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age. Orphanet J Rare Dis. 2020;15:25. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977247/
Ademhan Tural D, Emiralioglu N, Ozsezen B, et al. Clinical spectrum of children with interstitial pneumonia with autoimmune features. Respir Med. 2021;187:106566.
Garcelon N, Neuraz A, Salomon R, et al. A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse. J Biomed Inf. 2018;80:52-63.
Fan LL, Langston C. Chronic interstitial lung disease in children. Pediatr Pulmonol. 1993;16(3):184-196.
Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718-1727.
Fernandes L, Nasser M, Ahmad K, Cottin V. Interstitial pneumonia with autoimmune features (IPAF). Front Med. 2019;6:209. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798044/
Liptzin DR, Landau LI, Taussig LM. Sex and the lung: observations, hypotheses, and future directions: sex and the lung. Pediatr Pulmonol. 2015;50(12):1159-1169.
Ottaviani S, Khaleche S, Borie R, Debray M-P, Dieudé P, Crestani B. Rheumatological evaluation of patients with interstitial lung disease. Scand J Rheumatol. 2022;51(1):34-41.
Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease. Chest. 2011;140(5):1292-1299.
Hernandez-Gonzalez F, Prieto-González S, Brito-Zeron P, et al. Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases. Medicine. 2020;99(4):e18589.
Pouessel G, Deschildre A, Le Bourgeois M, et al. The lung is involved in juvenile dermatomyositis. Pediatr Pulmonol. 2013;48(10):1016-1025.
Aaløkken TM, Lilleby V, Søyseth V, et al. Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests. Acta Radiol. 2009;50(4):430-436.
Vece TJ, Fan LL. Interstitial lung disease in children older than 2 years. Pediatr Allergy Immunol Pulmonol. 2010;23(1):33-41.
Seely JM, Jones LT, Wallace C, Sherry D, Effmann EL. Systemic sclerosis: using high-resolution CT to detect lung disease in children. Am J Roentgenol. 1998;170(3):691-697.
Teel A, Lu J, Park J, Singh N, Basharat P. The role of myositis-specific autoantibodies and the management of interstitial lung disease in idiopathic inflammatory myopathies: a systematic review. Semin Arthritis Rheum. 2022;57:152088.